AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $110,000 | -50.9% | 21,325 | -9.5% | 0.00% | -33.3% |
| Q4 2015 | $224,000 | +26.6% | 23,562 | +9.9% | 0.00% | +50.0% |
| Q3 2015 | $177,000 | -52.3% | 21,447 | -6.2% | 0.00% | -60.0% |
| Q2 2015 | $371,000 | -57.8% | 22,865 | +5.2% | 0.01% | -50.0% |
| Q1 2015 | $880,000 | -0.3% | 21,729 | +32.8% | 0.01% | 0.0% |
| Q4 2014 | $883,000 | – | 16,361 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|